CCI Greenlights Abu Dhabi Investment Authority’s Stake Acquisition in Berhyanda Firms
The Competition Commission of India (CCI) has approved Abu Dhabi Investment Authority's (ADIA) acquisition of stakes in Berhyanda Ltd and Berhyanda MidCo Ltd through Platinum Poppy. The acquisition indirectly gives ADIA an economic interest in Suven Pharmaceuticals, a company engaged in manufacturing and selling active pharmaceutical ingredients in India.
![CCI Greenlights Abu Dhabi Investment Authority’s Stake Acquisition in Berhyanda Firms](https://devdiscourse.blob.core.windows.net/aiimagegallery/08_06_2024_13_52_44_5502859.png)
- Country:
- India
The Competition Commission of India (CCI) has granted its approval for the acquisition of stakes in Berhyanda Ltd and Berhyanda MidCo Ltd by Platinum Poppy, a subsidiary of the Abu Dhabi Investment Authority (ADIA).
Both Berhyanda and Berhyanda MidCo are wholly-owned investment holding firms managed by Advent International, LP. Platinum Poppy, incorporated in the Abu Dhabi Global Market, was established solely to invest in these entities.
This acquisition will give Platinum Poppy, and thereby ADIA, an indirect non-voting economic interest in Suven Pharmaceuticals Ltd as Berhyanda currently holds a 50.1% stake in Suven, a prominent manufacturer and seller of active pharmaceutical ingredients in India.
(With inputs from agencies.)
ALSO READ
Karnataka Government and Foxconn Discuss Major Investment Expansion Plans
Rajasthan Receives Massive Investment Boost Ahead of 'Rising Rajasthan' Summit 2024
Foxconn's USD 10 Billion India Investment: A Boon for Gender Equality
BPCL Bets Big on Petrochemicals and Green Energy with Rs 1.7 Lakh Crore Investment
Global Health Headlines: Polio in Gaza, Maternal Health Investments, Mpox Outbreaks, and More